Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816614) titled 'The Effect of Mandala Coloring on Quality of Life in Cancer Patients' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Emine TARLABELEN KARAYTUG
Condition:
Cancer
Neoplasms (Cancer / Tumors)
Intervention:
Behavioral: Mandala Coloring
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2026
Target Sample Size: 76
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07816614
Publ...